Vailhauques, France

Richard Roux


Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 319(Granted Patents)


Location History:

  • Vailhaiques, FR (1997 - 1998)
  • Vailhauques, FR (1991 - 2008)

Company Filing History:


Years Active: 1991-2008

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Richard Roux: Innovator in Pharmaceutical Chemistry

Introduction

Richard Roux, based in Vailhauques, France, is a prolific inventor in the field of pharmaceutical chemistry, holding an impressive portfolio of 21 patents. His work primarily revolves around novel compounds that can serve as potential therapeutic agents, particularly in relation to the Vreceptors of arginine-vasopressin.

Latest Patents

Among his latest inventions are the compounds identified as 1,3-dihydro-2H-indol-2-one derivatives, which have been meticulously designed to demonstrate high affinity and selectivity towards both the V1 and V2 receptors of arginine-vasopressin. These patents outline not only the compounds themselves but also a comprehensive process for their preparation. Additionally, they include detailed descriptions of intermediate compounds that are essential for synthesizing these innovative pharmaceutical compositions, highlighting their potential applications in medicinal products.

Career Highlights

Richard Roux has made significant strides in his career by actively working with notable companies such as Sanofi and Sanofi-Aventis. His tenure at these organizations has notably contributed to advancing pharmaceutical research and development through his innovative mindset and expertise in compound synthesis.

Collaborations

Throughout his career, Roux has collaborated with esteemed colleagues, including Georges Garcia and Jean Wagnon. These partnerships have enriched his work environment, fostering a culture of innovation and leading to fruitful outcomes in various projects.

Conclusion

Richard Roux continues to be a key figure in pharmaceutical innovation, with his extensive patent portfolio showcasing his commitment to advancing medicinal chemistry. His contributions hold great promise for the development of new therapeutic options, reflecting his significant impact on the field and the healthcare industry as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…